Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients

ClinicalTrials.gov ID: NCT01917630

Public ClinicalTrials.gov record NCT01917630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 30, 2026, 3:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the effects of 12 weeks administration of different dose levels of ALV003 on the mucosal lining of the small intestine and symptoms in celiac disease patients.

Study identification

NCT ID: NCT01917630
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Alvine Pharmaceuticals Inc.; Industry
Enrollment: 500 participants

Conditions and interventions

Conditions

Celiac Disease

Interventions

ALV003 Drug
placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2013 (Type not available)
Primary completion: Apr 2015 (Estimated)
Completion: Jun 2015 (Estimated)
Last update posted: Dec 17, 2014

2013 – 2015

United States locations

U.S. sites: 79
U.S. states: 32
U.S. cities: 73

Facility	City	State	ZIP	Site status
Not listed	Decatur	Alabama	35601	—
Not listed	Huntsville	Alabama	35801	—
Not listed	Huntsville	Alabama	35802	—
Not listed	Scottsdale	Arizona	85259	—
Not listed	Scottsdale	Arizona	85260	—
Not listed	Tucson	Arizona	85712	—
Not listed	Los Angeles	California	90025	—
Not listed	Los Angeles	California	90027	—
Not listed	Modesto	California	95355	—
Not listed	Newport Beach	California	92660	—
Not listed	Oceanside	California	92056	—
Not listed	Orange	California	92868	—
Not listed	Palo Alto	California	94301	—
Not listed	Poway	California	92064	—
Not listed	Roseville	California	95661	—
Not listed	San Diego	California	92114	—
Not listed	San Jose	California	95117	—
Not listed	San Marcos	California	92069	—
Not listed	Aurora	Colorado	80045	—
Not listed	Bridgeport	Connecticut	06606	—
Not listed	Boynton Beach	Florida	33426	—
Not listed	Hollywood	Florida	33021	—
Not listed	Jacksonville	Florida	32224	—
Not listed	Jacksonville	Florida	32256	—
Not listed	Largo	Florida	33777	—
Not listed	Miami	Florida	33137	—
Not listed	Miami	Florida	33165	—
Not listed	Naples	Florida	34102	—
Not listed	Orlando	Florida	32806	—
Not listed	Atlanta	Georgia	30328	—
Not listed	Idaho Falls	Idaho	83404	—
Not listed	Meridian	Idaho	83642	—
Not listed	Chicago	Illinois	60612	—
Not listed	Chicago	Illinois	60637	—
Not listed	Evanston	Illinois	60201	—
Not listed	Oak Lawn	Illinois	60453	—
Not listed	Des Moines	Iowa	50266	—
Not listed	Topeka	Kansas	66606	—
Not listed	Baltimore	Maryland	21229	—
Not listed	Chevy Chase	Maryland	20815	—
Not listed	Boston	Massachusetts	02215	—
Not listed	Chesterfield	Michigan	48047	—
Not listed	Wyoming	Michigan	49519	—
Not listed	Rochester	Minnesota	55905	—
Not listed	Jackson	Mississippi	39202	—
Not listed	Kansas City	Missouri	64131	—
Not listed	Mexico	Missouri	65265	—
Not listed	Marlton	New Jersey	08053	—
Not listed	Great Neck	New York	11023	—
Not listed	New York	New York	10032	—
Not listed	Poughkeepsie	New York	12601	—
Not listed	Rochester	New York	14618	—
Not listed	Asheville	North Carolina	28801	—
Not listed	Salisbury	North Carolina	28144	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Cincinnati	Ohio	45219	—
Not listed	Cleveland	Ohio	44122	—
Not listed	Dayton	Ohio	45415	—
Not listed	Mentor	Ohio	44060	—
Not listed	Oklahoma City	Oklahoma	73103	—
Not listed	Tulsa	Oklahoma	74104	—
Not listed	Portland	Oregon	97225	—
Not listed	Malvern	Pennsylvania	19355	—
Not listed	Philadelphia	Pennsylvania	19107	—
Not listed	Pittsburgh	Pennsylvania	15243	—
Not listed	Warwick	Rhode Island	02886	—
Not listed	Mt. Pleasant	South Carolina	29464	—
Not listed	Chattanooga	Tennessee	37421	—
Not listed	Hermitage	Tennessee	37076	—
Not listed	Houston	Texas	77094	—
Not listed	Irving	Texas	75063	—
Not listed	Southlake	Texas	76092	—
Not listed	West Jordan	Utah	84088	—
Not listed	Alexandria	Virginia	22304	—
Not listed	Virginia Beach	Virginia	23454	—
Not listed	Bellevue	Washington	98004	—
Not listed	Seattle	Washington	98104	—
Not listed	Madison	Wisconsin	53705	—
Not listed	Milwaukee	Wisconsin	53215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01917630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 17, 2014 · Synced Oct 30, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01917630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →